HO
Werewolf Therapeutics, Inc.
HOWL · NASDAQ
$0.97 +2.80% (+$0.03)
1M +143.34%
Market Cap $45.9M
P/E Ratio -
Div. Yield -
ROE 166.99%
Bulios Fair Price
$1.14
18.0% upside
Trenutna cena
$0.97
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica HOWL trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
71 /100
Cheap P/S 2.18x
P/B 2.82x
P/E N/A
Growth
0 /100
Declining Book val. growth 41.25%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 86.43%
FCF margin 143.56%
Net margin 164.82%
Quality
11 /100
Poor ROIC 156.97%
Asset turnover 0.87x
ROE 166.99%
Debt
69 /100
Low Debt/Equity 0.00x
Int. coverage -5.64x
Current ratio 2.91x
Stability
17 /100
Unstable Beta 0.29x
Profitable years 0
Rev. volatility 67.64%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o HOWL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel J. Hicklin
Employees
39
Headquarters
Watertown
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report